FMR LLC Raises Stake in Adamas Pharmaceuticals (ADMS) to 10.92%
Tweet Send to a Friend
In a 13G filing on Adamas Pharmaceuticals (NASDAQ: ADMS), hedge fund FMR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
